Premier Alternatives

Anodyne Nanotech

Boston, MA · Founded 2019 · Privately Held (backing)

Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases. Anodyne Nanotech is based in Boston, MA and was founded in 2019. Its last reported valuation was $7 million in Aug 2020. It has raised $9.6 million across 3 recorded rounds; the latest was a $12.6 million early-stage round in May 2026.

Last reported valuation
$7.0M
Oct 2026
Priced at
—
Total raised
$9.6M
Last round
Early Stage VC
May 2026

Anodyne Nanotech key facts

as of Oct 2026
  • Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases.
  • Anodyne Nanotech is valued at approximately $7.0M as of Oct 2026 (last reported valuation).
  • It has raised $9.6M across 3 recorded rounds; the latest was Early Stage VC ($12.6M) in May 2026.
  • Notable investors include Bantam Group, Endeavor Greece, Big Pi Ventures, New Ventures Pitch Competition, Relativity Healthcare Partners — 7 tracked in total.
  • Anodyne Nanotech has filed 3 Form Ds with the SEC since 2020, most recently May 2021 ($2.0M sold to 15 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$7.0M

Anodyne Nanotech's last reported valuation, Aug 2020. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Anodyne Nanotech with a free account
  • ·Watch Anodyne Nanotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Anodyne Nanotech funding rounds

3 rounds
May 2026Early Stage VC$12.6MSEC filing▮
Feb 2021Debt$2.0MSEC filing▮
Jul 2020Seed Round$1.5MSEC filing▮
Full funding history →

Anodyne Nanotech valuation

Anodyne Nanotech's last reported valuation was $7 million in Aug 2020. No priced round, secondary trade or fund mark has surfaced since.

How much has Anodyne Nanotech raised?

Anodyne Nanotech has raised $9.6 million across 3 recorded rounds since 2020. The largest was a $2 million debt round in Feb 2021; the most recent was a $12.6 million early-stage round in May 2026.

Anodyne Nanotech has filed 3 Form Ds with the SEC since 2020, most recently in May 2021 ($2 million sold to 15 investors).

Anodyne Nanotech investors

7 investors are on record for Anodyne Nanotech, including Bantam Group, Endeavor Greece, Big Pi Ventures and New Ventures Pitch Competition. The early-stage round in May 2026 drew 47 investors.

About Anodyne Nanotech

Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases. The company offers a patch-based platform licensed from Tufts University capable of delivering multi-milligram doses of biologics, enabling patients with obesity and related conditions to access alternatives to injectables and infusions while expanding treatment possibilities through combination therapies.

Sector
Healthcare
HQ
Boston, MA, United States
Founded
2019
Employees
20
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.